Skip to main content

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Search

1062 result(s) found, displaying 851 to 875
  • Australian Public Assessment Report for Trastuzumab
  • Australian Public Assessment Report for Vemurafenib
  • Australian Public Assessment Report for Infliximab
  • Australian Public Assessment Report for Vernakalant
  • Australian Public Assessment Report for Ivabradine
  • Australian Public Assessment Report for Belimumab
  • Australian Public Assessment Report for Terlipressin acetate
  • Australian Public Assessment Report for Aprepitant
  • Australian Public Assessment Report for Lapatinib
  • Australian Public Assessment Report for Budesonide
  • Australian Public Assessment Report for Abiraterone acetate
  • Australian Public Assessment Report for Tolvaptan
  • Australian Public Assessment Report for Telaprevir
  • Australian Public Assessment Report for Mifepristone
  • Australian Public Assessment Report for Misoprostol
  • Australian Public Assessment Report for Rivaroxaban
  • Australian Public Assessment Report for Bevacizumab
  • Australian Public Assessment Report for Aflibercept
  • Australian Public Assessment Report for Belatacept
  • Australian Public Assessment Report for Aspirin / Esomeprazole

Help us improve the Therapeutic Goods Administration site